High dose-rate tandem and ovoid brachytherapy in cervical cancer: dosimetric predictors of adverse events

BACKGROUND: Brachytherapy (BT) is a vital component of the curative treatment of locally advanced cervical cancer. The American Brachytherapy Society has published guidelines for high dose rate (HDR) BT with recommended dose limits. However, recent reports suggest lower doses may be needed to avoid...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Radiat Oncol
Hauptverfasser: Romano, Kara D., Hill, Colin, Trifiletti, Daniel M., Peach, M. Sean, Horton, Bethany J., Shah, Neil, Campbell, Dylan, Libby, Bruce, Showalter, Timothy N.
Format: Artigo
Sprache:Inglês
Veröffentlicht: BioMed Central 2018
Schlagworte:
Research
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6048838/
https://ncbi.nlm.nih.gov/pubmed/30012164
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13014-018-1074-2
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge